JP2807792B2 - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JP2807792B2
JP2807792B2 JP63293401A JP29340188A JP2807792B2 JP 2807792 B2 JP2807792 B2 JP 2807792B2 JP 63293401 A JP63293401 A JP 63293401A JP 29340188 A JP29340188 A JP 29340188A JP 2807792 B2 JP2807792 B2 JP 2807792B2
Authority
JP
Japan
Prior art keywords
skin
tetrahydroabietic acid
acid
external preparation
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP63293401A
Other languages
Japanese (ja)
Other versions
JPH02188513A (en
Inventor
佳浩 横川
勇二 包
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARIMA KASEI KK
Shiseido Co Ltd
Original Assignee
HARIMA KASEI KK
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HARIMA KASEI KK, Shiseido Co Ltd filed Critical HARIMA KASEI KK
Priority to JP63293401A priority Critical patent/JP2807792B2/en
Publication of JPH02188513A publication Critical patent/JPH02188513A/en
Application granted granted Critical
Publication of JP2807792B2 publication Critical patent/JP2807792B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は皮膚外用剤に関する。さらに詳しくはテトラ
ヒドロアビエチン酸および/またはそのエステル誘導体
を含有した皮膚外用剤に関する。
The present invention relates to an external preparation for skin. More specifically, the present invention relates to an external preparation for skin containing tetrahydroabietic acid and / or an ester derivative thereof.

すなわち、本発明は抗菌作用に優れ、しかも人体に安
全で安定性に優れた、医薬品、医薬部外品、化粧品等の
皮膚外用剤に関する。
That is, the present invention relates to an external preparation for skin such as pharmaceuticals, quasi-drugs, and cosmetics, which has an excellent antibacterial action and is safe and excellent in stability for the human body.

[従来の技術] 従来からアクネは、皮脂分泌の増加、細菌の感染等が
原因で起こることが、一般に知られている。すなわち、
皮脂が溜まってできた面皰に細菌の感染が起こり毛嚢の
炎症を生じ、膿疱あるいは、大きなしこりとなる。
[Prior Art] It is generally known that acne is caused by an increase in sebum secretion, bacterial infection and the like. That is,
Bacterial infection occurs in comedones formed by accumulation of sebum, causing hair follicle inflammation, resulting in pustules or large lumps.

天然から植物抽出により得られるもので、アクネ(尋
常性そう:Acne vulgaris)の原因菌とされるグラム陽
性嫌気性菌であるプロピオニバクテリウム アクネス
(Propionibacterium acnes)に対し有効な抗菌力を示
すものには、ピシフェリン酸、塩化ベルベリンなどが知
られている。
It is obtained from plant extracts from nature and exhibits effective antibacterial activity against Propionibacterium acnes, a Gram-positive anaerobic bacterium that is the causative agent of acne (Acne vulgaris) Are known such as piciferic acid and berberine chloride.

[発明が解決しようとする問題点] 従来技術の問題点 しかしながら、前記ピシフェリン酸、塩化ベルベリン
のアクネに対する効果は一応認められているもののその
効果は必ずしも満足のいくものではない。
[Problems to be Solved by the Invention] Problems in the Prior Art However, although the effects of piciferic acid and berberine chloride on acne have been recognized for some time, the effects are not always satisfactory.

発明の目的 前記したような事情に鑑み、本発明者らはアクネの抑
制に有効な植物成分を開発することを目的として鋭意研
究を重ねた結果、マツ科植物から抽出されるアビエチン
酸を水素添加して得られるテトラヒドロアビエチン酸お
よびそのエスエル誘導体が極めて安全性および安定性に
優れ、プロピオニバクテリウム アクネスに対して極め
て強い抗菌性を有することを認めた。
In view of the circumstances described above, the present inventors have conducted intensive studies with the aim of developing plant components that are effective in controlling acne, and as a result, hydrogenated abietic acid extracted from Pinaceae plants. It was confirmed that the tetrahydroabietic acid and its S-derivative obtained as described above were extremely excellent in safety and stability and had extremely strong antibacterial properties against Propionibacterium acnes.

テトラヒドロアビエチン酸またはそのエスエル誘導体
の抗菌性についての報告は全く見受けられず、皮膚外用
剤への応用はまったく知られていない。
No report has been found on the antibacterial properties of tetrahydroabietic acid or its derivative, and its application to skin external preparations is not known at all.

本発明者らは上記知見に基づいて本発明を完成するに
至った。
The present inventors have completed the present invention based on the above findings.

[問題点を解決するための手段] すなわち、本発明はテトラヒドロアビエチン酸および
/またはテトラヒドロアビエチン酸と低級アルコールと
のエステルを有効成分として含有することを特徴とする
抗菌用皮膚外用剤を提供するものである。
[Means for Solving the Problems] That is, the present invention provides an antibacterial skin external preparation characterized by containing tetrahydroabietic acid and / or an ester of tetrahydroabietic acid and a lower alcohol as an active ingredient. It is.

以下、本発明について詳述する。 Hereinafter, the present invention will be described in detail.

本発明の皮膚外用剤には、テトラヒドロアビエチン酸
および/またはそのエステル誘導体を任意の量含有して
良いが、通常、皮膚外用剤全量中に、乾燥残分量として
0.001〜10重量%含有されているのが望ましく、さらに
好ましくは0.1〜3重量%がアクネ原因菌に対する抗菌
力を示し適当である。0.001重量%未満では本発明の効
果が充分に得られず、また10重量%を超えると製剤上不
利である。
The external preparation for skin of the present invention may contain an arbitrary amount of tetrahydroabietic acid and / or an ester derivative thereof, but is usually contained as a dry residue in the total amount of external preparation for skin.
The content is desirably 0.001 to 10% by weight, more preferably 0.1 to 3% by weight, which shows antibacterial activity against acne-causing bacteria and is appropriate. If the amount is less than 0.001% by weight, the effect of the present invention cannot be sufficiently obtained, and if it exceeds 10% by weight, it is disadvantageous in terms of formulation.

本発明で用いられるテトラヒドロアビエチン酸または
その誘導体は植物由来のものであり、一種または二種以
上が適宜選択され用いられる。
The tetrahydroabietic acid or a derivative thereof used in the present invention is derived from a plant, and one or two or more kinds are appropriately selected and used.

本発明で用いられるテトラヒドロアビエチン酸エステ
ル誘導体は、テトラヒドロアビエチン酸をエステル化し
た誘導体で例えば、テトラヒドロアビエチン酸メチル、
テトラヒドロアビエチン酸エチル、テトラヒドロアビエ
チン酸イソプロピル、テトラヒドロアビエチン酸nブチ
ル等があげられ、これらの中から一種または二種以上が
適宜選択され用いられる。なお当該テトラヒドロアビエ
チン酸エステルは、一般的なエステル化の方法で製造す
ることができる。
The tetrahydroabietic acid ester derivative used in the present invention is a derivative obtained by esterifying tetrahydroabietic acid, for example, methyl tetrahydroabietic acid,
Ethyl tetrahydroabietic acid, isopropyl tetrahydroabietic acid, n-butyl tetrahydroabietic acid, and the like are used, and one or more of them are appropriately selected and used. The tetrahydroabietic acid ester can be produced by a general esterification method.

本発明の皮膚外用剤にはテトラヒドロアビエチン酸お
よび/またはそのエステル誘導体に加えて、皮膚外用剤
基剤として、皮膚外用剤のタイプに応じて、油分、水な
どを配合することができ、更に必要に応じて界面活性
剤、保湿剤、低級アルコール、増粘剤、香料、酸化防止
剤、キレート剤、色素、防腐防黴剤などの皮膚外用剤に
用いられる慣用成分を配合することができる。
In addition to tetrahydroabietic acid and / or its ester derivative, the skin external preparation of the present invention may further contain an oil, water, etc. as the skin external preparation base depending on the type of the skin external preparation. According to the above, conventional ingredients used in external preparations for skin such as surfactants, humectants, lower alcohols, thickeners, fragrances, antioxidants, chelating agents, pigments, antiseptic and fungicides can be blended.

本発明の皮膚外用剤の剤型は任意であり、溶液系、可
溶化系、乳化系、粉末分散系、水−油二層系、水−油−
粉末三層系等どのような剤型でもかまわない。
The dosage form of the skin external preparation of the present invention is arbitrary, and may be a solution type, a solubilizing type, an emulsifying type, a powder dispersing type, a water-oil two-layer type, a water-oil-
Any dosage form such as a powder three-layer system may be used.

また、本発明の皮膚外用剤の用途も任意であり、医薬
品、医薬部外品、化粧品、トイレタリー製品等に広く用
いられる。例えば化粧水、乳液、クリーム、パック、ヘ
アトニック、ヘアクリーム、シャンプー、ヘアリンス、
水性軟膏、油性軟膏等があげられる。
The use of the external preparation for skin of the present invention is also optional, and is widely used for pharmaceuticals, quasi-drugs, cosmetics, toiletries and the like. For example, lotion, emulsion, cream, pack, hair tonic, hair cream, shampoo, hair rinse,
Aqueous ointments, oily ointments and the like can be mentioned.

[実施例] 次に実施例をあげて本発明を更に具体的に説明する
が、本発明の範囲をこれ等の実施例に限定するものでは
ないことはいうまでもない。なお以下の例において、配
合量は重量%で示す。
[Examples] Next, the present invention will be described more specifically with reference to Examples, but it goes without saying that the scope of the present invention is not limited to these Examples. In addition, in the following examples, the compounding amount is shown by weight%.

試験例1 グラム陽性嫌気性菌に対する阻止効果 まず、グラム陽性嫌気性菌であるアクネ菌に対する成
育阻止効果を次の様にして調べた。
Test Example 1 Inhibitory Effect on Gram-Positive Anaerobic Bacteria First, the growth-inhibiting effect on Gram-positive anaerobic bacteria Acne was examined as follows.

培地にニッスイ社製GAM寒天培地を用いpHを7.3±0.1
に調整後、テトラヒドロアビエチン酸について、プロピ
オニバクテリウム アクネス標準菌株(ATCC 11827)に
対する最小発育阻止濃度(MIC)を測定し評価した。な
お比較例として、抗菌作用を有すると一般に認められる
物質(ビオゾール、塩化ベルベリン、チオキソロン、ア
ビエチン酸)のMICも測定した。
Using Nissui GAM agar medium as the medium, the pH was 7.3 ± 0.1.
After the adjustment, the minimum inhibitory concentration (MIC) of tetrahydroabietic acid with respect to the Propionibacterium acnes standard strain (ATCC 11827) was measured and evaluated. As a comparative example, MICs of substances generally recognized as having an antibacterial activity (biosol, berberine chloride, thioxolone, abietic acid) were also measured.

この結果、次の第1表に示すようにテトラヒドロアビ
エチン酸が強い抗菌力を有することが示唆された。
As a result, as shown in the following Table 1, it was suggested that tetrahydroabietic acid has a strong antibacterial activity.

試験例2 抗菌活性 培地としてABCM培地(栄研)を用い、オートクレーブ
で115℃、15分間加熱処理した。
Test Example 2 Antibacterial Activity Using an ABCM medium (Eiken) as a medium, heat treatment was performed in an autoclave at 115 ° C. for 15 minutes.

各試料の10%アセトン溶液0.05mlを濾紙ディスク(8m
mφ)に浸み込ませ、予めプロピオニバクテリウムアビ
ダム(Propionibacterium avidum,ATCC 25577)を接種
分散した寒天平板上に接着させ、37℃3日間嫌気培養し
た。培養終了時濾紙の周囲に生じる透明帯(プロピオニ
バクテリウムアビダム発育阻止帯)の直径を測定し、抗
菌力を判定した。
0.05 ml of a 10% acetone solution of each sample was placed on a filter paper disc (8 m
mφ), adhered on an agar plate in which Propionibacterium avidum (ATCC 25577) was inoculated and dispersed in advance, and anaerobically cultured at 37 ° C. for 3 days. At the end of the culture, the diameter of the transparent zone (propionibacterium avidum growth inhibition zone) formed around the filter paper was measured to determine the antibacterial activity.

結果を第2表に示す。 The results are shown in Table 2.

次に本発明にかかる皮膚外用剤の実施例について説明
する。
Next, examples of the external preparation for skin according to the present invention will be described.

なお、各実施例の皮膚外用剤とも、尋常製そう等の
各種細菌性皮膚疾患に優れた予防・改善効果を示した。
In addition, the external preparations for skin of each Example also exhibited excellent preventive and ameliorating effects on various bacterial skin diseases such as vulgaris.

実施例1:化粧水 配合成分 (1)テトラヒドロアビエチン酸 0.5 (2)グリセロール 2.0 (3)1,3ブチレングリコール 2.0 (4)クエン酸ソーダ 0.1 (5)エタノール 10.0 (6)ポリオキシエチレン オレイルアルコール 0.5 (7)パラベン 0.1 (8)精製水 残余 (製法) 上記成分(1)、(5)、(6)に及び(7)を室温
にて混合溶解し、同じく室温にて混合溶解した成分
(2)、(3)、(4)及び(8)中は撹拌添加して化
粧水を得た。
Example 1: Lotion Ingredients% (1) tetrahydroabietic acid 0.5 (2) Glycerol 2.0 (3) 1,3-butylene glycol 2.0 (4) sodium citrate 0.1 (5) Ethanol 10.0 (6) polyoxyethylene oleyl alcohol 0.5 (7) Paraben 0.1 (8) Purified water residue (Preparation method) The above components (1), (5), (6) and (7) were mixed and dissolved at room temperature, and the same component was mixed and dissolved at room temperature ( In 2), (3), (4) and (8), a lotion was obtained by stirring and adding.

比較例1:化粧水 実施例1において成分(1)のテトラヒドロアビエチ
ン酸を除いた以外は、全て実施例1と同様にして化粧水
を得た。
Comparative Example 1: Lotion A lotion was obtained in the same manner as in Example 1 except that the component (1) tetrahydroabietic acid was omitted.

実施例1及び比較例1の化粧水のプロピオニバクテリ
ウム アクネスに対する抗菌効果を以下のようにして測
定した。
The antibacterial effect of the lotion of Example 1 and Comparative Example 1 against Propionibacterium acnes was measured as follows.

培地にニッスイ社製GAM寒天培地を用いpH7.3±0.1に
調整後、オートクレーブで115℃15分間加熱処理し平板
寒天を得た。試料0.05mlを直径8mmの濾紙上にとり、予
めプロピオニバクテリウム アクネス標準菌株(ATCC 1
1827)を接種分散させたGAM寒天培地上に接着させ、37
℃、3日間嫌気培養を行ない、培養終了時濾紙の周囲に
生じる透明帯(プロピオニバクテリウム アクネス発育
防止帯)直径を測定し、抗菌力を判定した。
After adjusting the pH to 7.3 ± 0.1 using a GAM agar medium manufactured by Nissui as a medium, the plate was heated at 115 ° C. for 15 minutes in an autoclave to obtain a plate agar. A 0.05 ml sample was placed on a filter paper having a diameter of 8 mm, and the propionibacterium acnes standard strain (ATCC 1
1827) was adhered to the inoculated and dispersed GAM agar medium.
After anaerobic culture at 3 ° C. for 3 days, the diameter of a transparent zone (propionibacterium acnes growth prevention zone) formed around the filter paper at the end of the culture was measured to determine the antibacterial activity.

結果を第3表に示す。 The results are shown in Table 3.

第3表の結果から明らかなように、テトラヒドロアビ
エチン酸を配合した実施例1は発育防止帯直径が比較例
1のそれよりも大きく抗菌力が強いことを示している。
As is evident from the results in Table 3, Example 1 in which tetrahydroabietic acid was blended had a growth-inhibiting zone diameter larger than that of Comparative Example 1, indicating that the antibacterial activity was strong.

実施例2:クレンジングフォーム 配合成分 (1)テトラヒドロアビエチン酸 メチルエステル 0.5 (2)グリセリン 18.0 (3)パルミチン酸 10.0 (4)ステアリン酸 10.0 (5)ミリスチン酸 12.0 (6)ラウリン酸 4.0 (7)オレイルアルコール 1.0 (8)水酸化カリウム 6.0 (9)精製水 残余 (製法) 上記成分(9)に成分(8)を加えて加熱し、これに
成分(2)を添加してただちに70℃に加熱した後、同時
に予め加熱融解してあった成分(1)(3)(4)
(5)(6)及び(7)をかきまぜながら徐々に加え
た。添加後、暫く70℃程度の温度に保ち、けん化反応を
終了させてクレンジングフォームを得た。
Example 2: Cleansing foam compounding component % (1) Tetrahydroabietic acid methyl ester 0.5 (2) Glycerin 18.0 (3) Palmitic acid 10.0 (4) Stearic acid 10.0 (5) Myristic acid 12.0 (6) Lauric acid 4.0 (7) Oleyl alcohol 1.0 (8) Potassium hydroxide 6.0 (9) Purified water residue (Preparation method) Add component (8) to component (9) and heat. Add component (2) to this and immediately heat to 70 ° C. After that, the components (1), (3), and (4) previously heated and melted at the same time
(5) (6) and (7) were gradually added with stirring. After the addition, the temperature was kept at about 70 ° C. for a while, and the saponification reaction was terminated to obtain a cleansing foam.

実施例3:アクネクリーム 配合成分 (1)テトラヒドロアビエチン酸 0.1 (2)感光素201 0.003 (3)1,3ブチレングリコール 5.0 (4)ミツロウ 2.0 (5)セタノール 4.0 (6)還元ラノリン 10.0 (7)スクワラン 30.0 (8)パラベン 0.2 (9)ポリオキシエチレンモノソル ビタンモノラウリン酸エステル 2.0 (10)精製水 残余 (製法) 上記成分(10)に成分(3)を加えて加熱して70℃に
保った(水相部)。他の成分を混合し、加熱溶解して70
℃とした(油相部)。この油相部を水相部に加えて予備
乳化を行ない、ホモミキサーで均一に乳化し、O/Wクリ
ームを得た。
Example 3: Acne cream compounding component % (1) Tetrahydroabietic acid 0.1 (2) Photosensitizer 201 0.003 (3) 1,3 butylene glycol 5.0 (4) Beeswax 2.0 (5) Cetanol 4.0 (6) Reduced lanolin 10.0 (7) ) Squalane 30.0 (8) Paraben 0.2 (9) Polyoxyethylene monosol bitane monolaurate 2.0 (10) Purified water residue (Preparation method) Add component (3) to component (10), heat and maintain at 70 ° C (Aqueous phase). Mix the other ingredients, heat and dissolve 70
° C (oil phase). This oil phase was added to the aqueous phase to perform preliminary emulsification, and then uniformly emulsified with a homomixer to obtain an O / W cream.

実施例4:パック 配合成分 (1)テトラヒドロアビエチン酸 3.0 (2)酢酸ビニル樹脂エマルジョン 12.0 (3)ポリビニルアルコール 10.0 (4)オリーブ油 3.0 (5)ソルビット 5.0 (6)酸化チタン 15.0 (7)エタノール 10.0 (8)パラベン 0.1 (9)精製水 残余 (製法) 上記成分(9)に成分(5)を混合し、それに成分
(6)及び(2)を添加し、更に成分(3)を成分
(7)の一部で湿潤したものを添加し、70℃に加熱して
溶解した。次に残りの成分(7)に成分(1)及び
(8)を加えて混合し、最後に成分(4)を添加し、冷
却してパックを得た。
Example 4: Packing component % (1) Tetrahydroabietic acid 3.0 (2) Vinyl acetate resin emulsion 12.0 (3) Polyvinyl alcohol 10.0 (4) Olive oil 3.0 (5) Sorbit 5.0 (6) Titanium oxide 15.0 (7) Ethanol 10.0 (8) Paraben 0.1 (9) Purified water residue (Preparation method) The component (5) is mixed with the component (9), the components (6) and (2) are added thereto, and the component (3) is further added to the component (7). ) Was added and the mixture was heated to 70 ° C. and dissolved. Next, the components (1) and (8) were added to and mixed with the remaining component (7). Finally, the component (4) was added and the mixture was cooled to obtain a pack.

実施例5:ファンデーション 配合成分 (1)テトラヒドロアビエチン酸 0.2 (2)酸化チタン 13.0 (3)コロイダルカオリン 25.0 (4)タルク 44.85 (5)ベンガル 0.8 (6)黄酸化鉄 2.5 (7)黒酸化鉄 0.1 (8)流動パラフィン 8.0 (9)セスキオレイン酸ソルビタン 3.5 (10)グリセリン 2.0 (11)パラベン 0.2 (製法) 上記成分(5)〜(7)を混合し、粉砕機を通して平
均粒径1〜5μmに粉砕した。これを高速ブレンダーに
移し、成分(10)を加えて混合した。別に成分(1)、
(8)、(9)及び(11)を混合し、均一にしたものを
上記混合物に加えて更に均一に混合した。これを粉砕機
で処理し、ふるいを通し粒度を揃えた後、圧縮成型し、
ケーキ型ファンデーションを得た。
Example 5: Composition ratio of foundation (1) Tetrahydroabietic acid 0.2 (2) Titanium oxide 13.0 (3) Colloidal kaolin 25.0 (4) Talc 44.85 (5) Bengal 0.8 (6) Yellow iron oxide 2.5 (7) Black iron oxide 0.1 (8) Liquid paraffin 8.0 (9) Sorbitan sesquioleate 3.5 (10) Glycerin 2.0 (11) Paraben 0.2 (Production method) The above components (5) to (7) are mixed and passed through a pulverizer to obtain an average particle size of 1 to 5 μm. Crushed. This was transferred to a high speed blender, and component (10) was added and mixed. Separately, component (1),
(8), (9) and (11) were mixed and made uniform, and the mixture was added to the above-mentioned mixture and further uniformly mixed. This is treated with a crusher, and after passing through a sieve to make the particle size uniform, compression molding is performed.
A cake-type foundation was obtained.

実施例6:クリーム 配合成分 (1)テトラヒドロアビエチン酸 1.0 (2)テトラヒドロアビエチン酸 メチルエステル 1.0 (3)テトラヒドロアビエチン酸 ブチルエステル 1.0 (4)流動パラフィン 10.0 (5)1,3ブチレングリコール 5.0 (6)ミツロウ 2.0 (7)セタノール 4.0 (8)還元ラノリン 2.0 (9)スクワラン 30.0 (10)パラベン 0.2 (11)ポリオキシエチレンモノソル ビタンモノラウリン酸エステル 2.0 (12)精製水 残余 (製法) 上記成分(10)に成分(1)、(3)を加えて加熱し
て70℃に保った(水相部)。他の成分を混合し、加熱溶
解して70℃とした(油相部)。この油相部を水相部に加
えて予備乳化を行ない、ホモミキサーで均一に乳化し、
O/Wクリームを得た。
Example 6: Cream formulation component % (1) Tetrahydroabietic acid 1.0 (2) Tetrahydroabietic acid methyl ester 1.0 (3) Tetrahydroabietic acid butyl ester 1.0 (4) Liquid paraffin 10.0 (5) 1,3 butylene glycol 5.0 (6) ) Beeswax 2.0 (7) Cetanol 4.0 (8) Reduced lanolin 2.0 (9) Squalane 30.0 (10) Paraben 0.2 (11) Polyoxyethylene monosol bitane monolaurate 2.0 (12) Purified water Residue (Production method) The above components (10) ), Components (1) and (3) were added, and the mixture was heated and maintained at 70 ° C. (aqueous phase). The other components were mixed and dissolved by heating to 70 ° C. (oil phase). This oil phase is added to the aqueous phase to perform pre-emulsification, and is uniformly emulsified with a homomixer.
O / W cream was obtained.

実施例7:乳液 配合成分 (1)テトラヒドロアビエチン酸 0.5 (2)流動パラフィン 10.0 (3)ワセリン 4.0 (4)ステアリン酸 2.0 (5)セタノール 1.0 (6)グリセリルモノステアリン酸 エステル(自己乳化型) 2.0 (7)プロピレングリコール 7.0 (8)精製水 残余 (9)水酸化ナトリウム 0.4 (製法) (1)ないし(6)を混合し、加熱溶解後70℃に保つ
(油相)。(7)ないし(9)を混合溶解後、加熱し70
℃に保つ(水相)。油相を水相に加え、その後ホモミキ
サーで均一に乳化し、よくかきまぜながら30℃まで冷却
する。
Example 7: Emulsion component % (1) Tetrahydroabietic acid 0.5 (2) Liquid paraffin 10.0 (3) Vaseline 4.0 (4) Stearic acid 2.0 (5) Cetanol 1.0 (6) Glyceryl monostearate (self-emulsifying type) 2.0 (7) Propylene glycol 7.0 (8) Purified water residue (9) Sodium hydroxide 0.4 (Production method) Mix (1) to (6), and keep at 70 ° C after heating and dissolving (oil phase). After mixing and dissolving (7) to (9),
Keep at ° C (aqueous phase). The oil phase is added to the aqueous phase, and then uniformly emulsified with a homomixer and cooled to 30 ° C. with good stirring.

実施例8:油性軟膏 配合成分 (1)テトラヒドロアビエチン酸 0.5 (2)ショートニングオイル 3.0 (3)ワセリン 96.5 (製法) 上記成分を混合し、80℃まで加温し、徐々に冷却す
る。
Example 8: Oily ointment compounding component % (1) Tetrahydroabietic acid 0.5 (2) Shortening oil 3.0 (3) Vaseline 96.5 (Production method) The above components were mixed, heated to 80 ° C, and gradually cooled.

発明の効果 本発明は皮膚外用剤において、テトラヒドロアビエチ
ン酸および/またはそのエスエル誘導体を含むこととし
たので、尋常性そう等の各種細菌性皮膚疾患に対して
きわめて有効であり、安全性、安定性に優れた皮膚外用
剤である。
Effect of the Invention The present invention is intended to contain tetrahydroabietic acid and / or its derivative in a skin preparation for external use, so that it is extremely effective against various bacterial skin diseases such as vulgaris, and is safe and stable. It is an excellent external preparation for skin.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61K 7/00 A61K 31/19 C07C 61/135──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 6 , DB name) A61K 7/00 A61K 31/19 C07C 61/135

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】テトラヒドロアビエチン酸および/または
テトラヒドロアビエチン酸と低級アルコールとのエステ
ルを有効成分として含有することを特徴とする抗菌用皮
膚外用剤。
1. An antibacterial external preparation for skin, comprising as an active ingredient tetrahydroabietic acid and / or an ester of tetrahydroabietic acid and a lower alcohol.
JP63293401A 1988-11-18 1988-11-18 External preparation for skin Expired - Fee Related JP2807792B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63293401A JP2807792B2 (en) 1988-11-18 1988-11-18 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63293401A JP2807792B2 (en) 1988-11-18 1988-11-18 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH02188513A JPH02188513A (en) 1990-07-24
JP2807792B2 true JP2807792B2 (en) 1998-10-08

Family

ID=17794290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63293401A Expired - Fee Related JP2807792B2 (en) 1988-11-18 1988-11-18 External preparation for skin

Country Status (1)

Country Link
JP (1) JP2807792B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010418A1 (en) * 1990-01-19 1991-07-25 Shiseido Company, Ltd. Dermatologic preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798727B2 (en) * 1987-01-23 1995-10-25 株式会社資生堂 External skin preparation

Also Published As

Publication number Publication date
JPH02188513A (en) 1990-07-24

Similar Documents

Publication Publication Date Title
JPH10203955A (en) Antimicrobial low-irritating cosmetic
JP2700071B2 (en) Antimicrobial agent, skin external preparation and oral composition using the same
JPH1045563A (en) Antimicrobial and low-irritant cosmetic
JPH03178916A (en) Skin external agent
JP2819033B2 (en) An external preparation for skin or hair or a cosmetic containing a growth inhibitor of Propionibacterium acnes
JPH0532556A (en) Skin agent for external use
JP2807792B2 (en) External preparation for skin
JP2700070B2 (en) Antimicrobial agent for Gram-positive anaerobic bacteria, external preparation for skin and oral composition using the same
JPH1045557A (en) Antimicrobial and low-irritant cosmetic
JPS61205204A (en) External preparation for skin
JPH07138125A (en) Dermal agent for external use
JPH10203954A (en) Antimicrobial low-irritating cosmetic
JPH01275516A (en) Dandruff-preventive agent and hair-cosmetic
JPH11302147A (en) Cosmetic
JPH1072312A (en) Preparation for external use for skin
JPH07304634A (en) Hair tonic
JPH04217906A (en) Skin medicine for external use
JPH10203991A (en) Preparation for external use for skin
JPS6333326A (en) Antibacterial composition
JP2003034644A (en) Hyaluronidase inhibitor and skin care composition
US5292531A (en) Dermatologial external agent
JPH10182333A (en) Antimicrobial and low-irritation cosmetic
JPH10109923A (en) Antibacterial low irritant cosmetic material
JPS62267214A (en) Dermatic agent for external use
JP2001031554A (en) Preparation for external use for skin

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees